EKF Diagnostics (LON:EKF) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 25.66 and traded as low as GBX 25.20. EKF Diagnostics shares last traded at GBX 26, with a volume of 46,083 shares changing hands.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus reissued a “buy” rating and issued a GBX 35 target price on shares of EKF Diagnostics in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Stock Performance

The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77. The stock has a 50-day moving average price of GBX 26.19 and a two-hundred day moving average price of GBX 25.66. The stock has a market cap of £111.87 million, a PE ratio of 55.32 and a beta of 0.51.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.